BEXLUTRY
- Product NDC
- 69945-177
- Requested package NDC
- 69945-177-01
- 11-digit product format
- 699450177
- Labeler code
- 69945
- Product ID
- 69945-177_5ebf07f8-62f6-fd90-e063-6294a90ac739
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lutetium Lu 177 dotatate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Curium US LLC
- Application
- NDA218525
- Marketing category
- NDA
- Marketing start
- 2026-09-14
- Substance
- LUTETIUM OXODOTREOTIDE LU-177
- Active strength
- 10 mCi/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N218525-001 | BEXLUTRY | LUTETIUM LU-177 DOTATATE | 10mCi/ML | SOLUTION / INTRAVENOUS | RLD, RS | 2026-09-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N218525-001 | BEXLUTRY | 10mCi/ML | SOLUTION / INTRAVENOUS | RLD, RS | 2026-09-14 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N218525-001 | BEXLUTRY | 10mCi/ML | SOLUTION / INTRAVENOUS | RLD, RS | 2026-09-14 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BEXLUTRY
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LUTETIUM OXODOTREOTIDE LU-177 | 10 mCi/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| AE221IM3BB | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d7642094-9ec6-4927-8582-bbe60e5e74cc | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BEXLUTRY | LUTETIUM LU 177 DOTATATE | Curium US LLC | d7642094-9ec6-4927-8582-bbe60e5e74cc | 2026-10-26 | Warnings, Adverse reactions | 218525 NDA218525 69945-177-01 69945-177 69945017701 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69945-177-01 | 69945017701 | 20 mL in 1 VIAL, SINGLE-DOSE (69945-177-01) | 20 ml | 2026-09-14 | No | No | Current |